A Swiss pharmaceutical company with its manufacturing plant in Italy, serving as a center of excellence and innovation in biotech production of injectable sodium hyaluronate bulk (SHYALT® Ultrapure), PFS-HA crosslinked fillers, sterile impregnated gauzes, medicated patches and ODF, with deep regulatory expertise across the EU, USA, Korea, Brazil and UAE. The company is working toward higher IV ranges and expanded DMF and CEP coverage for parenteral use.

No comments available.
Leave your rating & comment